FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Mattson Technology

Sort
E.g., 2013-06-18
E.g., 2013-06-18
Enter a comma separated list of user names.

ARNA, Arena Pharmaceuticals, Inc.

** ARNA and Eisai Inc. reported that the FDA has accepted for filing and review ARNA's resubmission of the New Drug Application for lorcaserin.

According to the company, the FDA considers the resubmission a complete, class 2 response, and assigned a new Prescription Drug User Fee Act (PDUFA) target date of June 27, 2012.

ADVERTISE WITH US